Its Over, page-719

Promedicus (PME) is a value creator similar to CSL (before CSL became so big).


You just have to look at PME’s track record. Its Gross Profit Margin is incredible at 95%! There is literally nothing to pay out from its subscription or usage revenues and expenses growth is well controlled. This is the hallmark of a great and progressive smallcap (no longer microcap) and it is an investable share.

For all those who always like to use the phrase ‘this is for the bottom drawer’ for their liked microcaps , this is the real deal and the phrase is more applicable for this stock.

And if you noticed, good stocks have charts that is always going upwards, not down. PME stock chart looks like CSL when the latter was smaller then.

	Column 1	Column 2	Column 3	Column 4
0	PROMEDICUS	Half Yr 18	Half Yr 17	% incr
1	Half yearly Revenues	$  25,441	$ 15,892	60.1%
2	Gross Profit	$  24,181	$ 15,800	53.0%
3	GP%	95%	99%
4	Half yearly Expenses	$  10,942	$ 10,182	7.5%
5	Profit Before Tax	$  13,239	$   5,618	135.7%
6	Net Profit After Tax	$ 9,082	$   3,194	184.3%